FDA Expedites Durvalumab Review for Resectable Early-Stage Gastric, Gastroesophageal Cancers
Durvalumab continues to demonstrate efficacy in a variety of cancers, with new data from the phase 3 MATTERHORN trial solidifying…
Inconsistencies in Low-Density Lipoprotein Cholesterol Testing and Treatment After Revascularization
Patients with ASCVD face increased cardiovascular risks post-revascularization, yet many miss timely LDL-C testing and treatment, highlighting critical care gaps.
ENDO 2025: GLP-1 Receptor Agonists as Multisystem Therapies in Type 2 Diabetes Management
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses the expanding role of GLP-1 receptor agonists in holistic type 2 diabetes care,…
Lonapegsomatropin-Tcgd Receives FDA Approval for Growth Hormone Deficiency
FDA approves lonapegsomatropin for once-weekly treatment of growth hormone deficiency, offering a promising alternative for improved patient adherence and outcomes.
Fighting Financial Toxicity Through Oncology Drug Donation
George Wang discusses the widespread financial barriers cancer patients face, the environmental and economic toll of oncology drug waste, and…
Osimertinib With Chemotherapy Improves OS in Patients With EGFRm NSCLC
The combination regimen had stronger benefits in patients with locally advanced or metastatic epidermal growth receptor-mutated (EGFRm) non–small cell lung…
Thriving Amid Change: A Guide for Independent Specialty Pharmacies Considering Strategic Partnerships or Sale
Independent specialty pharmacies face growing financial and operational pressures from rising drug costs, restrictive PBM contracts, and regulatory complexity, prompting…
1047: A Case of Massive Enoxaparin Overdose
Show notes at pharmacyjoe.com/episode1047. In this episode, I’ll discuss a case report of enoxaparin overdose. The post 1047: A Case…
Study Explores the Survival Advantage of GLP-1s in Cancer Patients With Diabetes
GLP-1 receptor agonists show promise in improving survival rates for older cancer patients with type 2 diabetes (T2D), highlighting their…